Browse by Section 100 Item List
Highly Specialised Drugs Program (Private Hospital)
For Pharmaceutical Benefits Scheme (PBS) Highly Specialised Drugs prescribed through private hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Highly Specialised Drugs prescribed in private hospitals are Authority Required items. Application for authorisation can be made by either:
- posting an Authority Prescription form and other application form(s), where applicable to Services Australia
- using the form upload facility in Health Professional Online Services (HPOS)
- using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS)
- using the Services Australia free-call service for PBS Complex Drugs Programs enquiries (1800 700 270) or
- using the appropriate Streamlined code.
Prescribers must quote the provider number of the hospital when applying. Maximum quantities and repeats for Highly Specialised Drugs are listed in the PBS Schedule. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats.
Private hospital prescriptions for Highly Specialised Drugs can be dispensed by an approved private hospital dispensary or by a community pharmacy. A patient will be required to pay a contribution for each supply of a highly specialised drug at the same rate as the PBS.
The remuneration rates for Highly Specialised Drugs prescribed through private hospitals comprise the normal PBS ready-prepared dispensing fee plus a mark-up ascertained as follows:
- 10% for drugs with an ex-manufacturer price of less than $40
- $4 for drugs with an ex-manufacturer price of between $40 and $100
- 4% for drugs with an ex-manufacturer price of between $100.01 and $1000
- $40 for drugs with an ex-manufacturer price of greater than $1000.
Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.
- Legend
- MPMedical Practitioner
- NPNurse Practitioner
Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
---|---|---|---|---|---|
MP | 6320P | DARBEPOETIN ALFAdarbepoetin alfa 10 microgram/0.4 mL injection, 4 x 0.4 mL syringes | 2 | 8 | 5 |
MP | 6492Q | DARBEPOETIN ALFAdarbepoetin alfa 100 microgram/0.5 mL injection, 0.5 mL pen device | 8 | 8 | 5 |
MP | 6326Y | DARBEPOETIN ALFAdarbepoetin alfa 100 microgram/0.5 mL injection, 4 x 0.5 mL syringes | 2 | 8 | 5 |
MP | 6493R | DARBEPOETIN ALFAdarbepoetin alfa 150 microgram/0.3 mL injection, 0.3 mL pen device | 8 | 8 | 5 |
MP | 6365B | DARBEPOETIN ALFAdarbepoetin alfa 150 microgram/0.3 mL injection, 4 x 0.3 mL syringes | 2 | 8 | 5 |
MP | 6488L | DARBEPOETIN ALFAdarbepoetin alfa 20 microgram/0.5 mL injection, 0.5 mL pen device | 8 | 8 | 5 |
MP | 6321Q | DARBEPOETIN ALFAdarbepoetin alfa 20 microgram/0.5 mL injection, 4 x 0.5 mL syringes | 2 | 8 | 5 |
MP | 6322R | DARBEPOETIN ALFAdarbepoetin alfa 30 microgram/0.3 mL injection, 4 x 0.3 mL syringes | 2 | 8 | 5 |
MP | 6489M | DARBEPOETIN ALFAdarbepoetin alfa 40 microgram/0.4 mL injection, 0.4 mL pen device | 8 | 8 | 5 |
MP | 6323T | DARBEPOETIN ALFAdarbepoetin alfa 40 microgram/0.4 mL injection, 4 x 0.4 mL syringes | 2 | 8 | 5 |
MP | 6324W | DARBEPOETIN ALFAdarbepoetin alfa 50 microgram/0.5 mL injection, 4 x 0.5 mL syringes | 2 | 8 | 5 |
MP | 6490N | DARBEPOETIN ALFAdarbepoetin alfa 60 microgram/0.3 mL injection, 0.3 mL pen device | 8 | 8 | 5 |
MP | 6325X | DARBEPOETIN ALFAdarbepoetin alfa 60 microgram/0.3 mL injection, 4 x 0.3 mL syringes | 2 | 8 | 5 |
MP | 6491P | DARBEPOETIN ALFAdarbepoetin alfa 80 microgram/0.4 mL injection, 0.4 mL pen device | 8 | 8 | 5 |
MP | 6438W | DARBEPOETIN ALFAdarbepoetin alfa 80 microgram/0.4 mL injection, 4 x 0.4 mL syringes | 2 | 8 | 5 |
MP | 14170T | DAUNORUBICIN + CYTARABINEdaunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial | 3 | 3 | 4 |
MP | 14214D | DAUNORUBICIN + CYTARABINEdaunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial | 2 | 2 | 3 |
MP | 11236J | DEFERASIROXdeferasirox 125 mg dispersible tablet, 28 | 6 | 168 | 2 |
MP | 11241P | DEFERASIROXdeferasirox 125 mg dispersible tablet, 28 | 6 | 168 | 2 |
MP | 6499C | DEFERASIROXdeferasirox 125 mg dispersible tablet, 28 | 6 | 168 | 5 |
MP | 11238L | DEFERASIROXdeferasirox 250 mg dispersible tablet, 28 | 6 | 168 | 2 |
MP | 11244T | DEFERASIROXdeferasirox 250 mg dispersible tablet, 28 | 6 | 168 | 2 |
MP | 6500D | DEFERASIROXdeferasirox 250 mg dispersible tablet, 28 | 6 | 168 | 5 |
MP | 11232E | DEFERASIROXdeferasirox 500 mg dispersible tablet, 28 | 6 | 168 | 2 |
MP | 11243R | DEFERASIROXdeferasirox 500 mg dispersible tablet, 28 | 6 | 168 | 2 |
MP | 9600G | DEFERASIROXdeferasirox 500 mg dispersible tablet, 28 | 6 | 168 | 5 |
MP | 11510T | DEFERASIROXdeferasirox 180 mg tablet, 30 | 6 | 180 | 2 |
MP | 11546Q | DEFERASIROXdeferasirox 180 mg tablet, 30 | 6 | 180 | 5 |
MP | 11557G | DEFERASIROXdeferasirox 180 mg tablet, 30 | 6 | 180 | 2 |
MP | 11496C | DEFERASIROXdeferasirox 360 mg tablet, 30 | 6 | 180 | 5 |
MP | 11511W | DEFERASIROXdeferasirox 360 mg tablet, 30 | 6 | 180 | 2 |
MP | 11547R | DEFERASIROXdeferasirox 360 mg tablet, 30 | 6 | 180 | 2 |
MP | 11545P | DEFERASIROXdeferasirox 90 mg tablet, 30 | 6 | 180 | 5 |
MP | 11548T | DEFERASIROXdeferasirox 90 mg tablet, 30 | 6 | 180 | 2 |
MP | 11558H | DEFERASIROXdeferasirox 90 mg tablet, 30 | 6 | 180 | 2 |
MP | 9638G | DEFERIPRONEdeferiprone 100 mg/mL oral liquid, 250 mL | 5 | 5 | 5 |
MP | 6416Q | DEFERIPRONEdeferiprone 500 mg tablet, 100 | 3 | 300 | 5 |
MP | 11724C | DEFERIPRONEdeferiprone 1 g tablet, 50 | 6 | 300 | 5 |
MP | 6270B | DESFERRIOXAMINEdesferrioxamine mesilate 2 g injection, 1 vial | 60 | 60 | 5 |
MP | 6113R | DESFERRIOXAMINEdesferrioxamine mesilate 500 mg injection, 10 vials | 40 | 400 | 5 |
MP | 14106K | DIFELIKEFALINdifelikefalin 50 microgram/mL injection, 12 x 1 mL vials | 1 | 12 | 5 |
MP | 14110P | DIFELIKEFALINdifelikefalin 50 microgram/mL injection, 12 x 1 mL vials | 1 | 12 | 2 |
MP | 6120D | DORNASE ALFAdornase alfa 2.5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules | 2 | 60 | 5 |
MPNP | 6249X | DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL)doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial | 4 | 4 | 5 |
MP | 12294C | DUPILUMABdupilumab 300 mg/2 mL injection, 2 x 2 mL syringes | 1 | 2 | 5 |
MP | 12310X | DUPILUMABdupilumab 300 mg/2 mL injection, 2 x 2 mL syringes | 1 | 2 | 8 |
MP | 12313C | DUPILUMABdupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes | 1 | 2 | 8 |
MP | 12316F | DUPILUMABdupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes | 1 | 2 | 5 |